Browsing: rises

Eli Lilly (NYSE:LLY) just added another weapon to its obesity arsenal. The pharmaceutical giant received British authorization for Foundayo on Monday, making the U.K. the first European country to clear the once-daily orforglipron tablet for weight management and type 2 diabetes. Lilly shares rose approximately 2.1% in regular trading. The appeal is easy to understand:…

The so-called “Mediterranean diet” — rich in vegetables, legumes, olive oil, whole grains and fish — has long been regarded as the global benchmark for healthy eating patterns. Developed from the traditional eating habits of southern Italian communities in the 1950s, the diet gained global recognition after researchers linked it to remarkably low rates of…